{"id":33243,"date":"2024-02-02T07:43:34","date_gmt":"2024-02-02T13:43:34","guid":{"rendered":"https:\/\/brakkeconsulting.com\/?p=33243"},"modified":"2024-02-02T10:11:52","modified_gmt":"2024-02-02T16:11:52","slug":"animal-health-news-notes-for-february-2-2024","status":"publish","type":"post","link":"https:\/\/brakkeconsulting.com\/pt\/animal-health-news-notes-for-february-2-2024\/","title":{"rendered":"Not\u00edcias e notas sobre sa\u00fade animal de 2 de fevereiro de 2024"},"content":{"rendered":"<p>***********************************<br \/>\n<strong>Brakke Consulting&#039;s <\/strong><br \/>\n<strong>Not\u00edcias e notas sobre sa\u00fade animal de 2 de fevereiro de 2024<br \/>\n<\/strong><em>Copyright \u00a9 Brakke Consulting<br \/>\n<\/em><em>Editor: Lynn Fondon DVM MBA<br \/>\n<\/em>************************************<\/p>\n<p>NAS NOTICIAS:<br \/>\n<u>Not\u00edcias da Brakke Consulting<br \/>\n<\/u>Vis\u00e3o geral da ind\u00fastria na WVC<br \/>\nSemin\u00e1rios WVC gratuitos: Recrutamento e expans\u00e3o no mercado japon\u00eas<\/p>\n<p><u>Not\u00edcias de Ganhos<br \/>\n<\/u>Colinas<br \/>\nMerck<br \/>\nAnimais de estima\u00e7\u00e3o em casa<\/p>\n<p><u>Outras not\u00edcias<br \/>\n<\/u>Laborat\u00f3rios Veterin\u00e1rios de Alberta Ltd.\/Solvet<br \/>\nRede Blocktrust<br \/>\nBoehringer Ingelheim<br \/>\nChanelle Pharma<br \/>\nChr. Hansen<br \/>\nExpoente<br \/>\nF\u00e9lix Farmac\u00eautica<br \/>\nHuvepharma<br \/>\nci\u00eancia do instinto<br \/>\nInd\u00fastrias Kemin<br \/>\nMerck (Allflex)<br \/>\nMerck (Bravecto UE)<br \/>\nNovonese<br \/>\nNovozymes<br \/>\nMarcas de animais de estima\u00e7\u00e3o<br \/>\nGrupo de hospitalidade Pet Resort<br \/>\nPhageLab<br \/>\nPetCare direcionado<br \/>\nVetMedux<br \/>\nVytelle<br \/>\nParceiros Wind Point<br \/>\nZyVet Sa\u00fade Animal<\/p>\n<p><strong>*****************************************<br \/>\n<\/strong><strong>Brakke Consultoria<\/strong><br \/>\n<strong>Vis\u00e3o geral da ind\u00fastria em 2024<\/strong><\/p>\n<p><strong>Apresentado no WVC: segunda-feira, 19 de fevereiro<sup>\u00ba<\/sup>, 14h \u00e0s 16h, Hotel Four Seasons<\/strong><\/p>\n<p>Qual foi o desempenho das principais empresas de sa\u00fade animal em 2023? E quais quest\u00f5es cr\u00edticas impactar\u00e3o o desempenho da ind\u00fastria em 2024? As respostas a essas perguntas e muito mais ser\u00e3o abordadas na Vis\u00e3o Geral Anual da Ind\u00fastria da Brakke Consulting na confer\u00eancia WVC de 2024. Os principais t\u00f3picos e apresentadores incluem:<\/p>\n<ul>\n<li>Desempenho da ind\u00fastria e da empresa global de topo, <strong>apresentado por Bob Jones<\/strong><\/li>\n<li>Como foi 2023 nas cl\u00ednicas veterin\u00e1rias e com animais de estima\u00e7\u00e3o, <strong>apresentado por John Volk<\/strong><\/li>\n<li>Uma vis\u00e3o geral do canal de entrega em domic\u00edlio p\u00f3s-COVID de medicamentos para animais de estima\u00e7\u00e3o, incluindo resultados do novo <em>Estudo sobre entrega em domic\u00edlio de medicamentos para animais de estima\u00e7\u00e3o<\/em>, <strong>apresentado por Rich Hayworth<\/strong><\/li>\n<li>Com os recentes avan\u00e7os em produtos relacionados \u00e0 tecnologia na produ\u00e7\u00e3o pecu\u00e1ria e no cuidado de animais de estima\u00e7\u00e3o, onde est\u00e1 o valor e quais s\u00e3o os riscos?<strong> apresentado por Lourens Havenga<\/strong><\/li>\n<\/ul>\n<p>Al\u00e9m disso, voc\u00ea poder\u00e1 ouvir diretamente um painel dos principais l\u00edderes do setor de sa\u00fade animal.\u00a0 <strong>Moderado por Paul Casady<\/strong>, o tema do painel ser\u00e1 <strong>\u201cOportunidades e desafios em 2024.\u201d<\/strong> O painel para WVC ser\u00e1:<\/p>\n<ul>\n<li>Dan Markwalder, Diretor Veterin\u00e1rio, Mission Veterinary Partners.<\/li>\n<li>Dra. Christine Royal, vice-presidente de neg\u00f3cios de animais de companhia e equinos nos EUA, Merck Animal Health.<\/li>\n<\/ul>\n<p>Esta sess\u00e3o de 2 horas repleta de informa\u00e7\u00f5es ser\u00e1 especialmente valiosa para lideran\u00e7a executiva, gerentes de vendas e marketing, estrat\u00e9gia e finan\u00e7as e para tomadores de decis\u00e3o no setor de sa\u00fade animal.<\/p>\n<p><a href=\"https:\/\/brakkeconsulting.com\/pt\/produto\/2023-brakke-industry-overview-wvc-2\/\">Clique aqui para se cadastrar no WVC<\/a><\/p>\n<p>Voc\u00ea tamb\u00e9m pode <a href=\"mailto:amcdavid@brakkeconsulting.com?subject=Industry%20Overview\">e-mail Amanda McDavid\u00a0<\/a>ou ligue para 336-396-3916. O custo do registro \u00e9 $399; h\u00e1 descontos para v\u00e1rios participantes da mesma empresa. Estamos ansiosos para v\u00ea-lo l\u00e1!<\/p>\n<p><a href=\"https:\/\/brakkeconsulting.com\/pt\/\">www.BrakkeConsulting.com<\/a><\/p>\n<p><strong>*********************************************<br \/>\n<\/strong><strong>RELEASES DE NOT\u00cdCIAS DE GANHOS<\/strong><\/p>\n<ul>\n<li><strong>Merck<\/strong> anunciou os resultados financeiros para o ano inteiro de 2023. As vendas de Sa\u00fade Animal foram de $5.625 milh\u00f5es, um aumento ano a ano de 1% (+3% ajustado pela moeda). <em>(<\/em><a href=\"https:\/\/www.merck.com\/news\/merck-announces-fourth-quarter-and-full-year-2023-financial-results\/\"><em>comunicado de imprensa da empresa<\/em><\/a><em>)<\/em><\/li>\n<li>A Colgate-Palmolive Company relatou resultados para o ano inteiro de 2023. Vendas para <strong>Nutri\u00e7\u00e3o para animais de estima\u00e7\u00e3o da Hill&#039;s <\/strong>foram $4.290 milh\u00f5es, um aumento ano a ano de 16%. O lucro operacional do segmento foi de $806 milh\u00f5es, um decl\u00ednio de 5%.<em> (<\/em><a href=\"https:\/\/investor.colgatepalmolive.com\/news-releases\/news-release-details\/colgate-announces-4th-quarter-and-full-year-2023-results\"><em>comunicado de imprensa da empresa<\/em><\/a><em>)<\/em><\/li>\n<li><strong>Animais de estima\u00e7\u00e3o em casa<\/strong> reportou resultados para o terceiro trimestre do ano fiscal de 2024. As receitas foram de GBP 362,4 milh\u00f5es ($459,5M), um aumento de 4% em compara\u00e7\u00e3o com o trimestre do ano anterior. O grupo veterin\u00e1rio do varejista aumentou sua receita do terceiro trimestre em 13%.<em> (<\/em><a href=\"https:\/\/globalpetindustry.com\/article\/pets-at-home-closes-q3-with-below-expectation-retail-growth\"><em>Globalpets<\/em><\/a><em>)<\/em><\/li>\n<\/ul>\n<p><strong>*********************************************<br \/>\n<\/strong><strong>Brakke Consultoria<\/strong><br \/>\n<strong>Semin\u00e1rios gratuitos de 1 hora<br \/>\n<\/strong><strong>Segunda-feira, 19 de fevereiro de 2024 no WVC<br \/>\n<\/strong><strong>Hotel Four Seasons, Quarto Ac\u00e1cia<\/strong><\/p>\n<p><strong>Entrando no mercado japon\u00eas de sa\u00fade animal<br \/>\n<\/strong><strong>9h30 \u2013 10h30<br \/>\n<\/strong>Voc\u00ea gostaria de expandir seu neg\u00f3cio de animais de companhia fora dos EUA, mas n\u00e3o tem certeza de onde e agora? Que tal em um dos mercados mais valiosos do mundo, o Jap\u00e3o? A Brakke Consultoria pode ajudar.<\/p>\n<p>Pela primeira vez, a Brakke Consulting apresentar\u00e1 um semin\u00e1rio sobre como dar o primeiro passo no Jap\u00e3o na Confer\u00eancia Veterin\u00e1ria Ocidental na segunda-feira, 19 de fevereiro, das 9h30 \u00e0s 10h30, na sala Acacia 1 do Four Seasons Hotel. Este semin\u00e1rio ser\u00e1 apresentado por <strong>Yuki Ujimasa, DVM, MS,<\/strong> consultor s\u00eanior da Brakke baseado em T\u00f3quio, com ampla experi\u00eancia no mercado japon\u00eas. Yuki se concentrar\u00e1 nas etapas necess\u00e1rias para que seu produto seja aprovado pelas autoridades reguladoras do Jap\u00e3o. Este ser\u00e1 um \u00f3timo semin\u00e1rio para empresas que desejam expandir seus neg\u00f3cios globais, mas precisam de ajuda para come\u00e7ar. <strong>N\u00e3o h\u00e1 custo, mas por favor confirme presen\u00e7a\u00a0<\/strong><a href=\"https:\/\/aoxva-zgpvh.maillist-manage.net\/click\/1cd098dd5634d24c\/1cd098dd5634ae95\"><strong>aqui<\/strong><\/a><strong>\u00a0para garantir seu assento<\/strong>.<\/p>\n<p><strong>Semin\u00e1rio de Recrutamento<br \/>\n<\/strong><strong>11h00 \u2013 12h00<br \/>\n<\/strong>Contratando gestores e profissionais de talento, junte-se a n\u00f3s para um semin\u00e1rio informativo e pr\u00e1tico na VMX organizado pela Executive Recruiter <strong>Jeff Santosuosso<\/strong>. Analisaremos e discutiremos as formas mais recentes de romper com a desordem para atrair e contratar os melhores talentos no mercado global cada vez mais desafiador de hoje. Os t\u00f3picos espec\u00edficos incluir\u00e3o: atrair a gera\u00e7\u00e3o Y e a gera\u00e7\u00e3o Z, usar v\u00eddeo, como evitar armadilhas no recrutamento e muito mais. Se voc\u00ea est\u00e1 em busca de talentos, sabemos que sair\u00e1 do nosso semin\u00e1rio mais bem equipado e mais confiante para contratar essas estrelas para sua equipe.\u00a0 <strong>N\u00e3o h\u00e1 custo, mas por favor confirme presen\u00e7a\u00a0<\/strong><a href=\"https:\/\/aoxva-zgpvh.maillist-manage.net\/click\/1cd098dd5634d24c\/1cd098dd5634ae95\"><strong>aqui<\/strong><\/a><strong>\u00a0para garantir seu assento.<\/strong><\/p>\n<p><a href=\"https:\/\/brakkeconsulting.com\/pt\/\">www.BrakkeConsulting.com<\/a><\/p>\n<p><strong>**************************************<br \/>\n<\/strong><strong>COMUNICADOS DE NOT\u00cdCIAS DA EMPRESA<\/strong><\/p>\n<ul>\n<li><strong>Merck Sa\u00fade Animal<\/strong> anunciou a introdu\u00e7\u00e3o do redesenhado ALLFLEX A-Tag Feedlot V2 e do aplicador como parte de seu abrangente portf\u00f3lio de confinamento.<em> (comunicado de imprensa da empresa)<\/em><\/li>\n<li><strong>Boehringer Ingelheim<\/strong> anunciou o lan\u00e7amento da Vaxxilive Cocci 3, uma vacina contra coccidiose avi\u00e1ria anteriormente conhecida como Hatchpak Cocci III.<em> (<\/em><a href=\"https:\/\/www.feedstuffs.com\/agribusiness-news\/boehringer-ingelheim-poultry-coccidiosis-vaccine-returns-to-market-under-new-name-?Issue=FP-006_20240126_FP-006_801&amp;sfvc4enews=42&amp;cl=article_5_b&amp;utm_rid=CPG02000000634415&amp;utm_campaign=82342&amp;utm_medium=email&amp;elq2=8e7b29877d054ff0a6907c7c5c336fdb&amp;sp_eh=5ad5c0bd44d178ead75442954eeebed56ea20b1c3b898933d7317b319539a3c9\"><em>Ra\u00e7\u00e3o<\/em><\/a><em>)<\/em><\/li>\n<li>A FDA aprovou <strong>ZyVet Sa\u00fade Animal<\/strong>solu\u00e7\u00e3o t\u00f3pica gen\u00e9rica de Selamectina para uso em c\u00e3es e gatos. <em>(<\/em><a href=\"https:\/\/www.fda.gov\/animal-veterinary\/approved-animal-drug-products-green-book\/recent-animal-drug-approvals?utm_medium=email&amp;utm_source=govdelivery\"><em>FDA<\/em><\/a><em>)<\/em><\/li>\n<li>A FDA aprovou <strong>F\u00e9lix Farmac\u00eautica<\/strong>&#039;comprimidos gen\u00e9ricos com sabor de carprofeno para uso em c\u00e3es. <em>(<\/em><a href=\"https:\/\/www.fda.gov\/animal-veterinary\/approved-animal-drug-products-green-book\/recent-animal-drug-approvals?utm_medium=email&amp;utm_source=govdelivery\"><em>FDA<\/em><\/a><em>)<\/em><\/li>\n<li>A FDA aprovou <strong>Huvepharma<\/strong>Ravantage 9 e Ravantage 45 (artigo medicamentoso gen\u00e9rico de cloridrato de ractopamina Tipo A) para uso na termina\u00e7\u00e3o de su\u00ednos. <em>(<\/em><a href=\"https:\/\/www.fda.gov\/animal-veterinary\/approved-animal-drug-products-green-book\/recent-animal-drug-approvals?utm_medium=email&amp;utm_source=govdelivery\"><em>FDA<\/em><\/a><em>)<\/em><\/li>\n<li>Em resposta \u00e0 escassez de Folltropin (horm\u00f4nio fol\u00edculo estimulante) aprovado pela FDA, a FDA anunciou que n\u00e3o pretende se opor \u00e0 importa\u00e7\u00e3o tempor\u00e1ria de <strong>Alberta Veterinary Laboratories Ltd.\/Solvet&#039;s<\/strong> Pluset (horm\u00f4nio fol\u00edculo estimulante derivado da hip\u00f3fise su\u00edna e horm\u00f4nio luteinizante). Pluset est\u00e1 autorizado para comercializa\u00e7\u00e3o na Espanha e a importa\u00e7\u00e3o melhorar\u00e1 a disponibilidade do produto FSH para uso em bovinos nos EUA. <em>(<\/em><a href=\"https:\/\/www.fda.gov\/animal-veterinary\/cvm-updates\/fda-helps-improve-us-availability-fsh-important-drug-embryo-transfer-heifers-and-cows?utm_medium=email&amp;utm_source=govdelivery\"><em>FDA<\/em><\/a><em>)<\/em><\/li>\n<li><strong>Novozymes <\/strong>e<strong> Hansen<\/strong> anunciou a conclus\u00e3o de um acordo para criar <strong>Novonese<\/strong>, uma nova entidade, atrav\u00e9s de uma fus\u00e3o estatut\u00e1ria das duas empresas. O grupo combinado ter\u00e1 receitas anuais de aproximadamente 3,7 mil milh\u00f5es de euros.<em> (<\/em><a href=\"https:\/\/www.biospace.com\/article\/releases\/the-combination-of-novozymes-and-chr-hansen-is-now-successfully-completed-creating-novonesis-a-leading-global-biosolutions-partner\/\"><em>biospace.com<\/em><\/a><em>)<\/em><\/li>\n<li><strong>Ind\u00fastrias Kemin<\/strong> anunciou que o Centro de Medicina Veterin\u00e1ria da FDA aprovou o uso de propionato de cromo como fonte de cromo em dietas para perus em crescimento. De acordo com Kemin, o KemTRACE Chromium da empresa \u00e9 a \u00fanica fonte de propionato de cromo revisada pela FDA no mercado.<em> (<\/em><a href=\"https:\/\/www.prnewswire.com\/news-releases\/kemin-research-leads-to-fda-approval-of-chromium-propionate-for-use-in-growing-turkey-diets-302048178.html\"><em>prnewswire<\/em><\/a><em>)<\/em><\/li>\n<li><strong>PhageLab<\/strong>, uma empresa de biotecnologia que desenvolve aplica\u00e7\u00f5es baseadas em bacteri\u00f3fagos para a ind\u00fastria pecu\u00e1ria, anunciou uma rodada de financiamento de $11 milh\u00f5es. O financiamento permitir\u00e1 que a PhageLab avance em seu pipeline de solu\u00e7\u00f5es baseadas em fagos e estabele\u00e7a uma posi\u00e7\u00e3o comercial no Brasil, seu principal mercado-alvo, e expanda sua tecnologia para os EUA.<em> (<\/em><a href=\"https:\/\/www.feedstuffs.com\/nutrition-and-health\/phagelab-raises-11m-to-treat-bacterial-outbreaks-in-livestock?Issue=FP-006_20240131_FP-006_711&amp;sfvc4enews=42&amp;cl=article_4_b&amp;utm_rid=CPG02000000634415&amp;utm_campaign=82468&amp;utm_medium=email&amp;elq2=f11be1cf042c4410811f7e9f103819fd&amp;sp_eh=5ad5c0bd44d178ead75442954eeebed56ea20b1c3b898933d7317b319539a3c9\"><em>Ra\u00e7\u00e3o<\/em><\/a><em>)<\/em><\/li>\n<li><strong>PetCare direcionado<\/strong>, de propriedade de uma empresa de private equity <strong>Parceiros Wind Point<\/strong>, anunciou que comprou fornecedor de guloseimas para animais de estima\u00e7\u00e3o <strong>Marcas de animais de estima\u00e7\u00e3o<\/strong>. Termos financeiros n\u00e3o foram divulgados<em>. (<\/em><a href=\"https:\/\/newsletter.smartbrief.com\/getLast.action?mode=last&amp;b=PET\"><em>Produtos para animais de estima\u00e7\u00e3o SmartBrief<\/em><\/a><em>)<\/em><\/li>\n<li><strong>Grupo de hospitalidade Pet Resort<\/strong>, Trivest Partners e Queens Court Capital anunciaram a adi\u00e7\u00e3o de cinco marcas l\u00edderes de resorts para animais de estima\u00e7\u00e3o ao portf\u00f3lio da empresa, elevando o n\u00famero total de resorts para animais de estima\u00e7\u00e3o para 17. As aquisi\u00e7\u00f5es inclu\u00edram Meadowlake Pet Resort and Training Center (Houston, Texas); Resorts para animais de estima\u00e7\u00e3o em Olde Towne (DC); Playtime Pet Resort (Filad\u00e9lfia, Pensilv\u00e2nia); Paws &#039;n&#039; Rec (Tampa, Fl\u00f3rida); e Williamsburg Pet Hotel and Suites (St. Louis, Missouri). Os termos financeiros n\u00e3o foram divulgados. <em>(<\/em><a href=\"https:\/\/www.petage.com\/pet-resort-hospitality-group-announces-five-acquisitions-of-leading-pet-resort-brands\/\"><em>Idade do animal de estima\u00e7\u00e3o<\/em><\/a><em>)<\/em><\/li>\n<li><strong>ci\u00eancia do instinto<\/strong>, fornecedora de software para hospitais veterin\u00e1rios, anunciou que adquiriu <strong>VetMedux<\/strong>, uma empresa de educa\u00e7\u00e3o e informa\u00e7\u00f5es sobre pontos de atendimento que possui a Clinician&#039;s Brief e a Plumb&#039;s Veterinary Drugs. Os termos financeiros n\u00e3o foram divulgados.<em> (comunicado de imprensa da empresa)<\/em><\/li>\n<li><strong>Vytelle <\/strong>anunciou uma colabora\u00e7\u00e3o estrat\u00e9gica com <strong>Rede Blocktrust<\/strong> para aumentar a transpar\u00eancia e a efici\u00eancia na cadeia de abastecimento de carne bovina. A Vytelle desenvolver\u00e1 ferramentas para caracterizar diferen\u00e7as na efici\u00eancia alimentar entre grupos de bovinos alimentados por meio do blockchain autorizado da Blocktrust Network. <em>(comunicado de imprensa da empresa)<\/em><\/li>\n<li>IRLANDA <strong>Chanelle Pharma<\/strong> est\u00e1 sendo vendido para uma empresa de private equity do Reino Unido <strong>Expoente<\/strong> num neg\u00f3cio avaliado em cerca de 300 milh\u00f5es de euros.<em> (<\/em><a href=\"https:\/\/www.irishtimes.com\/business\/2024\/01\/28\/galways-channelle-pharma-poised-for-300m-sale-to-private-equity-firm\/\"><em>com<\/em><\/a><em>)<\/em><\/li>\n<li>UE <strong>Merck<\/strong> anunciou que a Comiss\u00e3o Europeia (CE) aprovou Bravecto (fluralaner) 150 mg\/ml p\u00f3 e solvente para suspens\u00e3o injet\u00e1vel para c\u00e3es. O produto \u00e9 aprovado para a morte imediata e persistente de pulgas e para a morte persistente de carrapatos de 3-4 dias a 12 meses.<em> (<\/em><a href=\"https:\/\/www.msd-animal-health.com\/2024\/01\/29\/eu-approval-injectable-bravecto\/\"><em>comunicado de imprensa da empresa<\/em><\/a><em>)<\/em><\/li>\n<\/ul>\n<p><strong>*********************************************<br \/>\n<\/strong><strong>RASTREADOR DE PRE\u00c7O DE A\u00c7\u00d5ES DE SA\u00daDE ANIMAL<\/strong><\/p>\n<p><img loading=\"lazy\" decoding=\"async\" class=\"alignnone wp-image-33245\" src=\"https:\/\/brakkeconsulting.com\/wp-content\/uploads\/2024\/02\/Screenshot-2024-02-01-214123.png\" alt=\"\" width=\"571\" height=\"421\" srcset=\"https:\/\/brakkeconsulting.com\/wp-content\/uploads\/2024\/02\/Screenshot-2024-02-01-214123.png 571w, https:\/\/brakkeconsulting.com\/wp-content\/uploads\/2024\/02\/Screenshot-2024-02-01-214123-480x354.png 480w\" sizes=\"(min-width: 0px) and (max-width: 480px) 480px, (min-width: 481px) 571px, 100vw\" \/><\/p>\n<p>***********************************<br \/>\n<strong>NOT\u00cdCIAS DE SA\u00daDE ANIMAL<\/strong><\/p>\n<ul>\n<li>EUA \u2013 REBANHO DE GADO O relat\u00f3rio mais recente do Servi\u00e7o Nacional de Estat\u00edsticas Agr\u00edcolas (NASS) do USDA revelou que todos os bovinos e bezerros nos EUA em 1\u00ba de janeiro de 2024 totalizavam 87,2 milh\u00f5es de cabe\u00e7as, 2% abaixo do rebanho do ano anterior. Este \u00e9 o menor invent\u00e1rio desde 1951. A produ\u00e7\u00e3o de bezerros, de 33,593 milh\u00f5es, \u00e9 a menor produ\u00e7\u00e3o de bezerros j\u00e1 registrada. <em>(<\/em><a href=\"https:\/\/www.feedstuffs.com\/market-news\/usda-cattle-inventory-numbers-show-further-decline-?Issue=FP-006_20240201_FP-006_544&amp;sfvc4enews=42&amp;cl=article_1_b&amp;utm_rid=CPG02000000634415&amp;utm_campaign=82500&amp;utm_medium=email&amp;elq2=f4f1e9e9a2514febbf3489dbebceb1ac&amp;sp_eh=5ad5c0bd44d178ead75442954eeebed56ea20b1c3b898933d7317b319539a3c9\"><em>Ra\u00e7\u00e3o<\/em><\/a><em>)<\/em><\/li>\n<\/ul>\n<p>************************************<br \/>\n<strong>PONTO DE VISTA DA BRAKKE CONSULTORIA<\/strong><br \/>\nDuas das principais feiras do setor acontecem em janeiro: VMX e IPPE, das quais tive a sorte de participar.<\/p>\n<p>Na VMX, houve muito entusiasmo e interesse \u00e0 medida que a ind\u00fastria continua a sua evolu\u00e7\u00e3o de volta aos dias \u201cnormais\u201d p\u00f3s-COVID. As empresas parecem cautelosamente optimistas, embora eu tenha ouvido v\u00e1rios relatos de controlos de custos implementados no quarto trimestre. Sempre achei esse movimento t\u00e1tico interessante - quando chega o quarto trimestre, e se voc\u00ea n\u00e3o estiver no caminho certo em termos de receitas ou despesas, boa sorte! \u00c9 como tentar parar um transatl\u00e2ntico.<\/p>\n<p>O IPPE tamb\u00e9m esteve lotado e bem frequentado, principalmente um grande contingente da LATAM. As preocupa\u00e7\u00f5es com a GAAP est\u00e3o na vanguarda de muitos produtores, mas a n\u00e3o vacina\u00e7\u00e3o ainda parece ser a posi\u00e7\u00e3o de muitos pa\u00edses. Face a eventos generalizados e a mais casos de esp\u00e9cies saltadoras de GAAP, pode ser que a ind\u00fastria tome uma ac\u00e7\u00e3o pr\u00f3-vacina\u00e7\u00e3o \u2013 n\u00e3o devido ao saneamento das aves, mas mais ao efeito ambiental sobre outros animais.<\/p>\n<p>Por \u00faltimo, a VMX aparentemente contou com a presen\u00e7a de lideran\u00e7as executivas de muitas empresas. \u00c9 evidente que a mesma lideran\u00e7a n\u00e3o era facilmente vis\u00edvel no IPPE. Na minha opini\u00e3o, a lideran\u00e7a da AH precisa de reconhecer a import\u00e2ncia da pecu\u00e1ria, mostrando apoio vis\u00edvel e interesse aos nossos clientes em participar nestes eventos importantes sobre animais para alimenta\u00e7\u00e3o - e n\u00e3o apenas nas grandes conven\u00e7\u00f5es de animais de companhia. As receitas e os lucros do segmento de produ\u00e7\u00e3o animal foram uma base s\u00f3lida da nossa ind\u00fastria no passado e continuar\u00e3o a s\u00ea-lo no futuro. As pessoas t\u00eam que comer!<\/p>\n<p><em>Paul Casady<\/em><\/p>\n<p>***********************************<br \/>\n<strong>SUA VIS\u00c3O<br \/>\n<\/strong>Na semana passada, perguntamos quais s\u00e3o os dois elementos que a McKinsey considera cr\u00edticos para uma inova\u00e7\u00e3o superior. 37% de voc\u00eas disseram que era mobiliza\u00e7\u00e3o e escala; outro 29% disse que era descobrir e evoluir. 24% disse que era aspirar e escolher; e 10% disse acelerar e aspirar. A resposta: <u>Aspirar<\/u> (Voc\u00ea considera cr\u00edtico o crescimento liderado pela inova\u00e7\u00e3o e estabeleceu metas em cascata que reflitam isso?) e <u>Escolher<\/u> (Voc\u00ea investe em um portf\u00f3lio de iniciativas coerente, equilibrado em termos de tempo e risco, e dedica recursos suficientes a ele?)<\/p>\n<p><strong>Essa semana<br \/>\n<\/strong>A not\u00edcia desta semana trouxe o an\u00fancio de que o Bravecto injet\u00e1vel de 12 meses da Merck foi aprovado na Europa. J\u00e1 est\u00e1 no mercado na Austr\u00e1lia e presumimos que estar\u00e1 dispon\u00edvel aqui nos EUA em breve.\u00a0 <a href=\"https:\/\/www.surveymonkey.com\/r\/2H6J57N\">O que voc\u00ea acha dos parasiticidas de a\u00e7\u00e3o ultralonga \u2013 voc\u00ea os usaria em seu pr\u00f3prio c\u00e3o?<\/a><\/p>","protected":false},"excerpt":{"rendered":"<p>*********************************** Not\u00edcias e notas sobre sa\u00fade animal da Brakke Consulting de 2 de fevereiro de 2024 Copyright \u00a9 Brakke Editora de Consultoria: Lynn Fondon DVM MBA ************************************ NAS NOT\u00cdCIAS: Brakke Consulting News Vis\u00e3o geral do setor no WVC Semin\u00e1rios gratuitos do WVC: Recrutamento e expans\u00e3o no mercado japon\u00eas Ganhos Not\u00edcias Hill&#039;s Merck Pets at Home Outras not\u00edcias Alberta Veterinary Laboratories Ltd.\/Solvet Blocktrust Network Boehringer Ingelheim Chanelle Pharma Chr. Hansen Expoente Felix Pharmaceuticals Huvepharma Instinct Science Kemin Industries Merck (Allflex) Merck (Bravecto EU) Novonesis Novozymes Pet Brands Pet Resort Hospitality Group PhageLab Targeted PetCare VetMedux Vytelle Wind Point Partners ZyVet Animal Health ************* **************************** Brakke Consulting 2024 Industry Overview apresentado no WVC: segunda-feira, 19 de fevereiro, das 14h \u00e0s 16h, Four Seasons Hotel Qual foi o desempenho das principais empresas de sa\u00fade animal em 2023? E quais quest\u00f5es cr\u00edticas impactar\u00e3o o desempenho da ind\u00fastria em 2024? As respostas a essas perguntas e muito mais ser\u00e3o abordadas na Vis\u00e3o Geral Anual da Ind\u00fastria da Brakke Consulting na confer\u00eancia WVC de 2024. Os principais t\u00f3picos e apresentadores incluem: Desempenho da ind\u00fastria e das principais empresas globais, apresentado por Bob Jones Como foi 2023 nas cl\u00ednicas veterin\u00e1rias e com animais de estima\u00e7\u00e3o, apresentado por John Volk Uma vis\u00e3o geral do canal de entrega em domic\u00edlio p\u00f3s-COVID para medicamentos para animais de estima\u00e7\u00e3o, incluindo resultados do novo Pet Medicines Home Delivery Study, apresentado por Rich Hayworth Com os recentes avan\u00e7os em produtos relacionados \u00e0 tecnologia na produ\u00e7\u00e3o pecu\u00e1ria e no cuidado de animais de estima\u00e7\u00e3o, onde est\u00e1<\/p>\n<div class=\"view-full-post\"><a href=\"https:\/\/brakkeconsulting.com\/pt\/animal-health-news-notes-for-february-2-2024\/\" class=\"view-full-post-btn\">Ver postagem completa<\/a><\/div>\n<p>;<\/p>","protected":false},"author":19,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"_et_pb_use_builder":"","_et_pb_old_content":"","_et_gb_content_width":"","footnotes":"","_links_to":"","_links_to_target":""},"categories":[1],"tags":[],"class_list":["post-33243","post","type-post","status-publish","format-standard","hentry","category-news"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.5 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>News from Brakke Consulting<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/brakkeconsulting.com\/pt\/animal-health-news-notes-for-february-2-2024\/\" \/>\n<meta property=\"og:locale\" content=\"pt_PT\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"News from Brakke Consulting\" \/>\n<meta property=\"og:description\" content=\"*********************************** Brakke Consulting&#8217;s Animal Health News &amp; Notes for February 2, 2024 Copyright \u00a9 Brakke Consulting Editor: Lynn Fondon DVM MBA ************************************ IN THE NEWS: Brakke Consulting News Industry Overview at WVC Complimentary WVC seminars: Recruiting and Expanding into the Japanese Market Earnings News Hill\u2019s Merck Pets at Home Other News Alberta Veterinary Laboratories Ltd.\/Solvet Blocktrust Network Boehringer Ingelheim Chanelle Pharma Chr. Hansen Exponent Felix Pharmaceuticals Huvepharma Instinct Science Kemin Industries Merck (Allflex) Merck (Bravecto EU) Novonesis Novozymes Pet Brands Pet Resort Hospitality Group PhageLab Targeted PetCare VetMedux Vytelle Wind Point Partners ZyVet Animal Health ***************************************** Brakke Consulting 2024 Industry Overview Presented at WVC: Monday, February 19th, 2-4 pm, Four Seasons Hotel How did the top animal health companies perform in 2023?\u00a0 And what critical issues will impact industry performance in 2024?\u00a0 Answers to these questions and more will be covered at Brakke Consulting\u2019s annual Industry Overview at the 2024 WVC conference.\u00a0 Key topics and presenters include: Industry and top global company performance, presented by Bob Jones What 2023 looked like in vet practices and with pets, presented by John Volk An overview of the post-COVID home delivery channel for pet medications including results from the new Pet Medicines Home Delivery Study, presented by Rich Hayworth With recent advancements in technology-related products in livestock production and pet care, where isView Full Post;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/brakkeconsulting.com\/pt\/animal-health-news-notes-for-february-2-2024\/\" \/>\n<meta property=\"og:site_name\" content=\"Brakke Consulting Website\" \/>\n<meta property=\"article:published_time\" content=\"2024-02-02T13:43:34+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2024-02-02T16:11:52+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/brakkeconsulting.com\/wp-content\/uploads\/2024\/02\/Screenshot-2024-02-01-214123.png\" \/>\n<meta name=\"author\" content=\"Amanda McDavid\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Escrito por\" \/>\n\t<meta name=\"twitter:data1\" content=\"Amanda McDavid\" \/>\n\t<meta name=\"twitter:label2\" content=\"Tempo estimado de leitura\" \/>\n\t<meta name=\"twitter:data2\" content=\"8 minutos\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/brakkeconsulting.com\\\/animal-health-news-notes-for-february-2-2024\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/brakkeconsulting.com\\\/animal-health-news-notes-for-february-2-2024\\\/\"},\"author\":{\"name\":\"Amanda McDavid\",\"@id\":\"https:\\\/\\\/brakkeconsulting.com\\\/#\\\/schema\\\/person\\\/cbd3330707aa1f20925a2f9d78722615\"},\"headline\":\"Animal Health News &#038; Notes for February 2, 2024\",\"datePublished\":\"2024-02-02T13:43:34+00:00\",\"dateModified\":\"2024-02-02T16:11:52+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/brakkeconsulting.com\\\/animal-health-news-notes-for-february-2-2024\\\/\"},\"wordCount\":1753,\"image\":{\"@id\":\"https:\\\/\\\/brakkeconsulting.com\\\/animal-health-news-notes-for-february-2-2024\\\/#primaryimage\"},\"thumbnailUrl\":\"http:\\\/\\\/brakkeconsulting.com\\\/wp-content\\\/uploads\\\/2024\\\/02\\\/Screenshot-2024-02-01-214123.png\",\"articleSection\":[\"Newsletter\"],\"inLanguage\":\"pt-PT\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/brakkeconsulting.com\\\/animal-health-news-notes-for-february-2-2024\\\/\",\"url\":\"https:\\\/\\\/brakkeconsulting.com\\\/animal-health-news-notes-for-february-2-2024\\\/\",\"name\":\"News from Brakke Consulting\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/brakkeconsulting.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/brakkeconsulting.com\\\/animal-health-news-notes-for-february-2-2024\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/brakkeconsulting.com\\\/animal-health-news-notes-for-february-2-2024\\\/#primaryimage\"},\"thumbnailUrl\":\"http:\\\/\\\/brakkeconsulting.com\\\/wp-content\\\/uploads\\\/2024\\\/02\\\/Screenshot-2024-02-01-214123.png\",\"datePublished\":\"2024-02-02T13:43:34+00:00\",\"dateModified\":\"2024-02-02T16:11:52+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/brakkeconsulting.com\\\/#\\\/schema\\\/person\\\/cbd3330707aa1f20925a2f9d78722615\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/brakkeconsulting.com\\\/animal-health-news-notes-for-february-2-2024\\\/#breadcrumb\"},\"inLanguage\":\"pt-PT\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/brakkeconsulting.com\\\/animal-health-news-notes-for-february-2-2024\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"pt-PT\",\"@id\":\"https:\\\/\\\/brakkeconsulting.com\\\/animal-health-news-notes-for-february-2-2024\\\/#primaryimage\",\"url\":\"http:\\\/\\\/brakkeconsulting.com\\\/wp-content\\\/uploads\\\/2024\\\/02\\\/Screenshot-2024-02-01-214123.png\",\"contentUrl\":\"http:\\\/\\\/brakkeconsulting.com\\\/wp-content\\\/uploads\\\/2024\\\/02\\\/Screenshot-2024-02-01-214123.png\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/brakkeconsulting.com\\\/animal-health-news-notes-for-february-2-2024\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/brakkeconsulting.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Animal Health News &#038; Notes for February 2, 2024\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/brakkeconsulting.com\\\/#website\",\"url\":\"https:\\\/\\\/brakkeconsulting.com\\\/\",\"name\":\"Brakke Consulting Website\",\"description\":\"\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/brakkeconsulting.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"pt-PT\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/brakkeconsulting.com\\\/#\\\/schema\\\/person\\\/cbd3330707aa1f20925a2f9d78722615\",\"name\":\"Amanda McDavid\",\"url\":\"https:\\\/\\\/brakkeconsulting.com\\\/pt\\\/author\\\/amanda\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Not\u00edcias da Brakke Consulting","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/brakkeconsulting.com\/pt\/animal-health-news-notes-for-february-2-2024\/","og_locale":"pt_PT","og_type":"article","og_title":"News from Brakke Consulting","og_description":"*********************************** Brakke Consulting&#8217;s Animal Health News &amp; Notes for February 2, 2024 Copyright \u00a9 Brakke Consulting Editor: Lynn Fondon DVM MBA ************************************ IN THE NEWS: Brakke Consulting News Industry Overview at WVC Complimentary WVC seminars: Recruiting and Expanding into the Japanese Market Earnings News Hill\u2019s Merck Pets at Home Other News Alberta Veterinary Laboratories Ltd.\/Solvet Blocktrust Network Boehringer Ingelheim Chanelle Pharma Chr. Hansen Exponent Felix Pharmaceuticals Huvepharma Instinct Science Kemin Industries Merck (Allflex) Merck (Bravecto EU) Novonesis Novozymes Pet Brands Pet Resort Hospitality Group PhageLab Targeted PetCare VetMedux Vytelle Wind Point Partners ZyVet Animal Health ***************************************** Brakke Consulting 2024 Industry Overview Presented at WVC: Monday, February 19th, 2-4 pm, Four Seasons Hotel How did the top animal health companies perform in 2023?\u00a0 And what critical issues will impact industry performance in 2024?\u00a0 Answers to these questions and more will be covered at Brakke Consulting\u2019s annual Industry Overview at the 2024 WVC conference.\u00a0 Key topics and presenters include: Industry and top global company performance, presented by Bob Jones What 2023 looked like in vet practices and with pets, presented by John Volk An overview of the post-COVID home delivery channel for pet medications including results from the new Pet Medicines Home Delivery Study, presented by Rich Hayworth With recent advancements in technology-related products in livestock production and pet care, where isView Full Post;","og_url":"https:\/\/brakkeconsulting.com\/pt\/animal-health-news-notes-for-february-2-2024\/","og_site_name":"Brakke Consulting Website","article_published_time":"2024-02-02T13:43:34+00:00","article_modified_time":"2024-02-02T16:11:52+00:00","og_image":[{"url":"https:\/\/brakkeconsulting.com\/wp-content\/uploads\/2024\/02\/Screenshot-2024-02-01-214123.png","type":"","width":"","height":""}],"author":"Amanda McDavid","twitter_card":"summary_large_image","twitter_misc":{"Escrito por":"Amanda McDavid","Tempo estimado de leitura":"8 minutos"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/brakkeconsulting.com\/animal-health-news-notes-for-february-2-2024\/#article","isPartOf":{"@id":"https:\/\/brakkeconsulting.com\/animal-health-news-notes-for-february-2-2024\/"},"author":{"name":"Amanda McDavid","@id":"https:\/\/brakkeconsulting.com\/#\/schema\/person\/cbd3330707aa1f20925a2f9d78722615"},"headline":"Animal Health News &#038; Notes for February 2, 2024","datePublished":"2024-02-02T13:43:34+00:00","dateModified":"2024-02-02T16:11:52+00:00","mainEntityOfPage":{"@id":"https:\/\/brakkeconsulting.com\/animal-health-news-notes-for-february-2-2024\/"},"wordCount":1753,"image":{"@id":"https:\/\/brakkeconsulting.com\/animal-health-news-notes-for-february-2-2024\/#primaryimage"},"thumbnailUrl":"https:\/\/brakkeconsulting.com\/wp-content\/uploads\/2024\/02\/Screenshot-2024-02-01-214123.png","articleSection":["Newsletter"],"inLanguage":"pt-PT"},{"@type":"WebPage","@id":"https:\/\/brakkeconsulting.com\/animal-health-news-notes-for-february-2-2024\/","url":"https:\/\/brakkeconsulting.com\/animal-health-news-notes-for-february-2-2024\/","name":"Not\u00edcias da Brakke Consulting","isPartOf":{"@id":"https:\/\/brakkeconsulting.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/brakkeconsulting.com\/animal-health-news-notes-for-february-2-2024\/#primaryimage"},"image":{"@id":"https:\/\/brakkeconsulting.com\/animal-health-news-notes-for-february-2-2024\/#primaryimage"},"thumbnailUrl":"https:\/\/brakkeconsulting.com\/wp-content\/uploads\/2024\/02\/Screenshot-2024-02-01-214123.png","datePublished":"2024-02-02T13:43:34+00:00","dateModified":"2024-02-02T16:11:52+00:00","author":{"@id":"https:\/\/brakkeconsulting.com\/#\/schema\/person\/cbd3330707aa1f20925a2f9d78722615"},"breadcrumb":{"@id":"https:\/\/brakkeconsulting.com\/animal-health-news-notes-for-february-2-2024\/#breadcrumb"},"inLanguage":"pt-PT","potentialAction":[{"@type":"ReadAction","target":["https:\/\/brakkeconsulting.com\/animal-health-news-notes-for-february-2-2024\/"]}]},{"@type":"ImageObject","inLanguage":"pt-PT","@id":"https:\/\/brakkeconsulting.com\/animal-health-news-notes-for-february-2-2024\/#primaryimage","url":"https:\/\/brakkeconsulting.com\/wp-content\/uploads\/2024\/02\/Screenshot-2024-02-01-214123.png","contentUrl":"https:\/\/brakkeconsulting.com\/wp-content\/uploads\/2024\/02\/Screenshot-2024-02-01-214123.png"},{"@type":"BreadcrumbList","@id":"https:\/\/brakkeconsulting.com\/animal-health-news-notes-for-february-2-2024\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/brakkeconsulting.com\/"},{"@type":"ListItem","position":2,"name":"Animal Health News &#038; Notes for February 2, 2024"}]},{"@type":"WebSite","@id":"https:\/\/brakkeconsulting.com\/#website","url":"https:\/\/brakkeconsulting.com\/","name":"Site da Brakke Consulting","description":"","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/brakkeconsulting.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"pt-PT"},{"@type":"Person","@id":"https:\/\/brakkeconsulting.com\/#\/schema\/person\/cbd3330707aa1f20925a2f9d78722615","name":"Amanda McDavid","url":"https:\/\/brakkeconsulting.com\/pt\/author\/amanda\/"}]}},"_links":{"self":[{"href":"https:\/\/brakkeconsulting.com\/pt\/wp-json\/wp\/v2\/posts\/33243","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/brakkeconsulting.com\/pt\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/brakkeconsulting.com\/pt\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/brakkeconsulting.com\/pt\/wp-json\/wp\/v2\/users\/19"}],"replies":[{"embeddable":true,"href":"https:\/\/brakkeconsulting.com\/pt\/wp-json\/wp\/v2\/comments?post=33243"}],"version-history":[{"count":2,"href":"https:\/\/brakkeconsulting.com\/pt\/wp-json\/wp\/v2\/posts\/33243\/revisions"}],"predecessor-version":[{"id":33254,"href":"https:\/\/brakkeconsulting.com\/pt\/wp-json\/wp\/v2\/posts\/33243\/revisions\/33254"}],"wp:attachment":[{"href":"https:\/\/brakkeconsulting.com\/pt\/wp-json\/wp\/v2\/media?parent=33243"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/brakkeconsulting.com\/pt\/wp-json\/wp\/v2\/categories?post=33243"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/brakkeconsulting.com\/pt\/wp-json\/wp\/v2\/tags?post=33243"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}